Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
ESTEVE CDMO expands US footprint with Regis Technologies acquisition
Hepatocellular carcinoma in the crosshairs with new treatment
A new path in cancer immunotherapy
Dx&Vx signs co-development and license agreement for mRNA cancer vaccine
Fast Track designation for severe alopecia areata treatment
Boehringer Ingelheim and Re-Vana Therapeutics to collaborate on ophthalmic therapies
MapLight Therapeutics raises $372.5m
Positive results for Energenesis Biomedical Parkinson’s disease treatment